Development of a combined storage medium for 7-day storage of platelet concentrates and 42-day storage of red cell concentrates

British Journal of Haematology
W HeatonT Keegan

Abstract

Studies were carried out to examine whether a single additive solution could support both platelet and red cell storage. An ionically balanced electrolyte solution fortified with citrate, glucose and bicarbonate was used. This solution has previously been shown to provide good platelet viability with storage for up to 7 d. Optimization studies demonstrated that with adenine added to this solution (CSM), it also allowed for satisfactory preservation of in vitro red cell parameters for up to 49 d of storage. Confirmatory paired in vivo post-transfusion studies were carried out in which platelets and red cells obtained from the same donor were processed and stored in CSM on one occasion, and in CPD-plasma (platelets) and AS-1 (red cells) on another occasion. Five paired studies were conducted with platelets stored for 5 d and red cells for 42 d; another five paired studies with platelets stored for 7 d and red cells for 49 d. Except for a slight decrease in platelet survival (P less than 0.05) with storage in CSM, there were no statistically significant differences in post-transfusion recoveries and survivals between test and control media, demonstrating that both platelets and red cells may be satisfactorily stored in a combined ...Continue Reading

References

Aug 1, 1979·British Journal of Haematology·W A HeatonB A Siegel
Dec 21, 1978·The New England Journal of Medicine·C F HögmanH Zetterström
Jul 1, 1977·Transfusion·E R Simon
Aug 6, 1977·The Medical Journal of Australia·V A LovricA Parker
Jan 1, 1989·Vox Sanguinis·E FagioloV Aureli
Nov 1, 1985·Transfusion·G RockG A Adams
May 1, 1971·British Journal of Haematology·L Garby, P L Mollison
Jul 1, 1984·British Journal of Haematology·A HeatonD H Buchholz

❮ Previous
Next ❯

Citations

Sep 1, 1992·British Journal of Haematology·T E KeeganE J Nelson
Jan 1, 1995·Immunological Investigations·W A Heaton
Apr 16, 2011·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Maria I C Gyongyossy-Issa
Jun 2, 2010·Clinics in Laboratory Medicine·Dana V Devine, Katherine Serrano
Jul 26, 2003·Transfusion Medicine·R Cardigan, L M Williamson
Jan 21, 2009·Vox Sanguinis·T PottgiesserY O Schumacher
Dec 20, 1999·Transfusion Medicine Reviews·C F Högman, H T Meryman
Jun 24, 2004·Vox Sanguinis·S J Slichter
Sep 28, 2006·Transfusion·Jorge A RiosLaurence Corash
Mar 6, 2003·Vox Sanguinis·C V Prowse, I R MacGregor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angelman Syndrome

Angelman syndrome is a neurogenetic imprinting disorder caused by loss of the maternally inherited UBE3A gene and is characterized by generalized epilepsy, limited expressive speech, sleep dysfunction, and movement disorders. Here is the latest research.